Skip to main content
SpringerLink
Log in

Dermatologische Erkrankungen und ihre Bedeutung für die Psychiatrie

Dermatological diseases and their importance for psychiatry

  • Übersichten
  • Published:
Der Nervenarzt Aims and scope Submit manuscript

Zusammenfassung

Der Zusammenhang zwischen Haut- und psychischen Erkrankungen tritt in der klinischen Praxis nicht selten auf, jedoch gibt es bis heute nur wenige Untersuchungen dazu, zu dem fehlen Kenntnisse über entsprechende bedingende neurobiologische und immunologische Mechanismen. Dabei können Veränderungen und Erkrankungen der Haut oftmals ein (frühes) Zeichen für eine psychische Störung sein. Im Sinne einer wahren „Psycho-Somatik“ sollten also Psychiater bestmöglich über diesen Zusammenhang Bescheid wissen. Diese Übersicht thematisiert die wichtigsten dermatologischen Diagnosen in Beziehung zu ihren jeweiligen psychischen Komorbiditäten und benennt die wichtigsten Aspekte bez. Epidemiologie, Symptomatik, Pathophysiologie und Behandlungsoptionen.

Abstract

The relationship between skin and psychiatric disorders is not an uncommon occurrence in the clinical practice; however, there are only a few systematic studies and in addition knowledge about the neurobiological and immunological mechanisms is lacking. Impairments and disorders of the skin are often an (early) sign of a psychiatric disorder. In the sense of true psychosomatics, psychiatrists should also be aware of this relationship as far as possible. This review article focuses on the most important dermatological diagnoses in relation to the respective psychiatric comorbidities and presents the most important aspects of epidemiology, symptomatology, pathophysiology and treatment options.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3
Abb. 4

Literatur

  1. Katsarou-Katsari A, Filipou A, Theoharides TC (1999) Effect of stress and other psychological factors on the pathophysiology and treatment of dermatoses. Int J Immunopathol Pharmacol 12:7–11

    CAS  PubMed  Google Scholar 

  2. Zouboulis CC, Böhm M (2004) Neuroendocrine regulation of sebocytes: a pathogenetic link between stress and acne. Exp Dermatol 13:31–35

    Article  CAS  PubMed  Google Scholar 

  3. Arck PC, Slominski A, Theoharides TC, Peters EMJ, Paus R (2006) Neuroimmunology of stress: skin takes center stag. J Invest Dermatol 126:1697–1704

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Steinhoff M, Schauber J, Leyden JJ (2013) New insights into rosacea pathophysiology: a review of recent findings. J Am Acad Dermatol 69(Suppl 1):15–26

    Article  CAS  Google Scholar 

  5. Tey HL, Wallengren J, Yosipovitch G (2013) Psychosomatic factors in pruritu. Clin Dermatol 31:31–40

    Article  PubMed  PubMed Central  Google Scholar 

  6. Buske-Kirschbaum A (2009) Cortisol responses to stress in allergic children: interaction with the immune response. Neuroimmunomodulation 16:325–332

    Article  CAS  PubMed  Google Scholar 

  7. Slominski A, Zbytek B, Nikolakis G, Manna PR, Skobowiat C, Zmijewski M, Li W, Janjetovic Z, Postlethwaite A, Zouboulis CC, Tuckey RC (2013) Steroidgenesis in the skin: implications for local immune functions. J Steroid Biochem Mol Biol 137:107–123

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Gupta MA, Gupta AK (2003) Psychiatric and psychological co-morbidity in patients with dermatologic disorders: epidemiology and management. Am J Clin Dermatol 4:833–842

    Article  PubMed  Google Scholar 

  9. Leon A, Levin EC, Koo YM (2013) Psychodermatology: an overview. Semin Cutan Med Surg 32:64–67

    Article  PubMed  Google Scholar 

  10. Wessely SC, Lewis GH (1989) The classification of psychiatric morbidity in attenders at a dermatology clinic. Br J Psychiatry 155:686–691

    CAS  PubMed  Google Scholar 

  11. Aktan S, Ozmen E, Sanli B (1998) Psychiatric disorders in patients attending a dermatology outpatient clinic. Dermatology 197:230–234

    Article  CAS  PubMed  Google Scholar 

  12. Picardi A, Abeni D, Melchi CF, Puddu P, Pasquini P (2000) Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br J Dermatol 143:983–991

    Article  CAS  PubMed  Google Scholar 

  13. Koo J, Lebwohl A (2001) Psychodermatology: the mind and skin connection. Am Fam Physician 64:1873–1879

    CAS  PubMed  Google Scholar 

  14. Gieler U, Niemeier V, Kupfer J, Brosig B, Schill WB (2001) Psychosomatische Dermatologie in Deutschland. Eine Umfrage an 69 Hautkliniken. Hautarzt 52:104–110

    Article  CAS  PubMed  Google Scholar 

  15. Moftah NH, Kamel AM, Attia HM, El-Baz MZ, Abd El-Moty HM (2013) Skin diseases in patients with primary psychiatric conditions: A hospital based study. J Epidemiol Glob Health 3:131–138

    Article  PubMed  Google Scholar 

  16. Dalgard FJ, Gieler U, Tomas-Aragones L, Lien L, Poot F, Jemec GBE, Misery L, Szabo C, Linder D, Sampogna F, Evers AWM, Halvorsen JA, Balieva F, Szepietowski J, Romanov D, Marron SE, Altunay IK, Finlay AY, Salek SS, Kupfer J (2015) The psychological burden of skin diseases: A cross-sectional multicenter study among dermatological out patients in 13 European countries. J Invest Dermatol 135:984–991

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Mookhoeck EJ, Van De Kerkhof PC, Hovens JE, Brouwers JR, Loonen AJ (2010) Skin disorders in chronic psychiatric illness. J Eur Acad Dermatol Venereol 24:1151–1156

    Article  Google Scholar 

  18. Mookhoeck EJ, Van De Kerkhof PC, Hovens JE, Brouwers JR, Loonen AJ (2011) Substantial skin disorders in psychiatric illness coincide with diabetes and addiction. J Eur Acad Dermatol Venereol 25:392–397

    Article  Google Scholar 

  19. Makigami K, Ohtaki N, Yasumura S (2012) A 35-month prospective study on onset of scabies in a psychiatric hospital: discussion on patient transfer and incubation period. J Dermatol 39:160–163

    Article  PubMed  Google Scholar 

  20. Kawai M, Suzuki T, Hiruma M, Ikeda S (2014) A retrospective cohort study of tinea pedis and tinea unguium in inpatients in a psychiatric hospital. Med Mycol J 55:E35–41

    Article  PubMed  Google Scholar 

  21. Sheikhmoonesi F, Hajheidari Z, Masoudzadeh A, Mohammadpour RA, Mozaffari M (2014) Prevalence and severity of obsessive-compulsive disorder and their relationships with dermatological diseases. Acta Med Iran 52:511–514

    PubMed  Google Scholar 

  22. Demet MM, Deveci A, Taskin EO, Ermertcan AT, Yurtsever F, Deniz F, Bayraktar D, Ozturkcan S (2005) Obsessive-compulsive disorder in a dermatology outpatient clinic. Gen Hosp Psychiatry 27:426–430

    Article  PubMed  Google Scholar 

  23. Fineberg NA, O’Doherty C, Rajagopal S, Reddy K, Banks A, Gale TM (2003) How common is obsessive-compulsive disorder in a dermatology outpatient clinic? J Clin Psychiatry 64:152–155

    Article  PubMed  Google Scholar 

  24. Deutsche Dermatologische Gesellschaft (DDG) (Taube M) (2006) AWMF online-S2-Leitlinie Psychosomatische Dermatologie (Reg.Nr. 013/024)

  25. Yadav S, Narang T, Kumaran MS (2013) Psychodermatology: a comprehensive review. Indian J Dermatolgy Venereol Leprol 79:176–192

    Article  Google Scholar 

  26. Basavaraj KH, Nawa MA, Rashmi R (2010) Relevance of psychiatry in dermatology: Present concepts. Indian J Psychiatry 52:270–275

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Lee CS, Koo J (2003) Psychocutaneus drug therapy. Semin Cutan Med Surg 22:222–233

    Article  PubMed  Google Scholar 

  28. Poot F, Sampogna F, Onnis L (2007) Basic knowledge in psychodermatology. JEADV 21:227–234

    CAS  PubMed  Google Scholar 

  29. Brown GE, Malakouti M, Sorenson E, Gupta R, Koo JYM (2015) Psychodermatology. In: Balon R, Wise TN (Hrsg) Clinical challenges in the biopsychosocial interface. Update on psychsomatics for the 21st centrury, Bd. 34. Karger, Basel, S 123–134 (Adv Psychosom Med)

    Chapter  Google Scholar 

  30. Chung WL, Ng SS, Koh MJA, Peh LH, Liu T (2012) A review of patients managed at acombined psychodermatology clinic: a Singapore experience. Singabore Med J 53:789–793

    Google Scholar 

  31. Shenefelt PD (2011) Psychodermatological disorders: recognition and treatment. Int J Dermatol 50:1309–1322

    Article  PubMed  Google Scholar 

  32. Falkai P, Wittchen HU (Hrsg) (2014) Diagnostisches und Statistisches Manual Psychischer Störungen (DSM V). Hogrefe, Göttingen

    Google Scholar 

  33. Dilling H, Freyberger HJ (Hrsg) (1999) Internationale Klassifikation psychischer Störungen (ICD-10). Hans Huber, Bern

    Google Scholar 

  34. Willemsen R, Roseeuw D, Vanderlinden J (2008) Alexithymia and dermatology: the state of the art. Int J Dermatol 47:903–910

    Article  PubMed  Google Scholar 

  35. Sifneos PE (1973) The prevalence of “alexithymic” characteristics in psychosomatic patients. Psychother Psychosom 22:255–262

    Article  CAS  PubMed  Google Scholar 

  36. Dieris-Hirche J (2013) Psychosoziale Faktoren der Neurodermitis im Erwachsenenalter. Dissertation

  37. Saitta P, Keehan P, Yousif J, Way BV, Grekin S, Brancaccio R (2011a) An update on the presence of psychiatric comorbidities in Acne patients, Part 1: overwiew of prevalence. Cutis 88:33–40

    PubMed  Google Scholar 

  38. Saitta P, Keehan P, Yousif J, Way BV, Grekin S, Brancaccio R (2011b) An update on the presence of psychiatric comorbidities in Acne patients, Part 2: depression, anxiety and suicide. Cutis 88:90–97

    Google Scholar 

  39. Fried RG, Wechsler A (2006) Psychological problems in the acne patient. Dermatol Ther 19:237–240

    Article  PubMed  Google Scholar 

  40. Hull PR, D’Arcy C (2005) Acne, depression and suicide. Dermatol Clin 23:665–674

    Article  CAS  PubMed  Google Scholar 

  41. Harth W, Gieler U (2006) Psychosomatische Dermatologie. Springer Medizin, Heidelberg

    Google Scholar 

  42. Simpson EL (2012) Comorbidity in atopic dermatitis. Curr Dermatol Rep 1(1):29–38

    Article  PubMed  PubMed Central  Google Scholar 

  43. Schmitt J, Apfelbacher C, Chen CM, Romanos M, Sausenthaler S, Koletzko S, Bauer CP, Hoffmann U, Krämer U, Berdel D, von Berg A, Wichmann HE, Heinrich J, German Infant Nutrition Intervention Group (2010) Infant-onset eczema in relation to mental health problems advantage 10 years: results from a prospective birth cohort study (German Infant Nutrition Intervention; GINI plus). J Allergy Clin Immunol 125:404–410

    Article  PubMed  Google Scholar 

  44. Schmitt J, Chen CM, Apfelbacher C, Romanos M, Lehmann I, Herbarth O, Schaaf B, Krämer U, von Berg A, Wichmann HE, Heinrich J, LISA-plus study Group (2010) Infant eczema, infant sleeping problems, and mental health at 10 years of age: the prospective birth cohort study LISA plus. Allergy 66:404–411

    Article  PubMed  Google Scholar 

  45. Slattery MJ, Essex MJ, Paletz EM, Vaness ER, Infante M, Rogers GM, Gern JE (2011) Depression anxxiety and dermatologic quality of life in adolescents with atopic dermatitis. J Allergy Clin Immunol 128:668–671

    Article  PubMed  PubMed Central  Google Scholar 

  46. Slattery MJ, Essex MJ (2011) Specificity in the association of anxiety, depression and atopic disorders in a community sample of adolescents. J Psychiatr Res 45:788–795

    Article  PubMed  Google Scholar 

  47. Romanos M, Schmitt J (2012) Atopic dermatitis and ADHD. MMW Fortschr Med 154:52–53

    Article  PubMed  Google Scholar 

  48. Schmitt J, Apfelbacher C, Heinrich J, Weidinger S, Romanos M (2013) Association of atopic eczema and attention-deficit/hyperactivity disorder-meta-analysis of epidemiologic studies. Z Kinder Jugendpsychiatr Psychother 41:35–42

    Article  PubMed  Google Scholar 

  49. Yaghmaie P, Koudelka CW, Simpson EL (2013) Mental health comorbidity in atopic dermatitis. J Allergy Clin Immunol 131:428–433

    Article  PubMed  Google Scholar 

  50. Buske-Kirschbaum A, Schmitt J, Plessow F, Romanos M, Weidinger S, Roessner V (2013) Psychoedocrine and psychoneuroimmunological mechanisms in the comorbidity of atopic eczema and attention deficit/hyperactivity disorder. Psychoendocrinology 38:12–23

    Article  CAS  Google Scholar 

  51. Cheng CM, Hsu JW, Huang KL, Bai YM, Su TP, Li CT, Yang AC, Chang WH, Chen TJ, Tsai SJ, Chen MH (2015) Risk developing major depressive disorder and anxiety disorders among adolescents and adults with atopic dermatitis: a nationwide longitudinal study. J Affect Disord 178:60–65

    Article  PubMed  Google Scholar 

  52. Dorst J, Seikowski K (2012) Skin, bonding and partnership in atopic dermatitis and psoriasis. Hautarzt 63:214–220

    Article  CAS  PubMed  Google Scholar 

  53. Dieris-Hirche J, Milch WE, Kupfer J, Leweke F, Gieler U (2012) Atopic dermatitis attachment and partnership: a psychodermatological case control-study of adult patients. Acta Derm Venereol 92:462–466

    Article  PubMed  Google Scholar 

  54. Senra MS, Wollenberg A (2014) Psychodermatological aspects of atopic dermatitis. Br J Dermatol 1:38–43

    Article  CAS  Google Scholar 

  55. Dieris-Hirche J, Gieler U, Kupfer J, Milch WE (2009) Suicidal ideation, anxiety and depression in adult patients with atopic dermatitis. Hautarzt 60:641–646

    Article  CAS  PubMed  Google Scholar 

  56. Hashizume H, Takigawa M (2006) Anxiety in allergy and atopic dermatitis. Curr Opin Allergy Clin Immunol 6:335–339

    Article  CAS  PubMed  Google Scholar 

  57. Mina S, Jabeen M, Singh S, Verma R (2015) Gender differences in depression and anxiety among atopic dermatitis patients. Indian J Dermatol 60:211–219

    PubMed  PubMed Central  Google Scholar 

  58. Shenefelt PD (2008) Therapeutic management of psychodermatological disorders. Expert Opin Pharmacother 9:973–985

    Article  CAS  PubMed  Google Scholar 

  59. Strutton DR, Kowalski JW, Glaser DA, Stang PE (2004) US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from national survey. J Am Acad Dermatol 51:241–248

    Article  PubMed  Google Scholar 

  60. Mourikis I, Zervas I (2008) Disorders of sweating in psychiatry. Psychiatriki 19:59–72

    CAS  PubMed  Google Scholar 

  61. Gross KM, Schote AB, Schneider KK, Schulz A, Meyer J (2014) Elevated social stress levels and depressive symptoms in primary hyperhidrosis. PLOS ONE 9(3):e92412

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  62. Hamm H, Naumann MK, Kowalski JW, Kütt S, Kozma C, Teale C (2006) Primary focal hyperhidrosis: disease characteristics and functional impairment. Dermatology 212(4):343–353

    Article  PubMed  Google Scholar 

  63. Vorkamp T, Foo FJ, Khan S, Schmitto JD, Wilson P (2010) Hyperhidrosis: evolving concepts and a comprehensive review. Surgeon 8:287–292

    Article  PubMed  Google Scholar 

  64. De Moura NB Junior, das-Neves-Pereira JC, de Oliveira FR, Jatene FB, Parra ER, Capelozzi VL, Wolosker N, de Campos JR (2013) Expression of atecylcholine and its receptor in human synthetic ganglia in primary hyperhidrosis. Ann Thorac Surg 95:465–470

    Article  Google Scholar 

  65. Fineberg JP (2014) Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: focus on modulation of CNS monamine neurotransmitter release. Pharmacol Ther 143(2):133–152

    Article  CAS  Google Scholar 

  66. Higley MJ, Picciotto MR (2014) Neuromodulation by acetylcholine: examples from schizophrenia and depression. Curr Opin Neurobiol 29:88–95

    Article  CAS  PubMed  Google Scholar 

  67. Gordon JL, Girdler SS, Meltzer-Brody SE, Stika CS, Thurston RC, Clark CT, Prairie BA, Moses-Kolko E, Joffe H, Wisner KL (2015) Ovarian hormone fluctuation, neurosteroids, and HPA axis dysregulation in perimenopausal depression: a novel heuristic model. Am J Psychiatry 172(3):227–236

    Article  PubMed  PubMed Central  Google Scholar 

  68. Lessa L, Luz F, Rezende R, Duraes S, Harrison B, Menezes G, Fontenelle L (2014) The psychiatric facet of hyperhidrosis: demographics, disability, quality of life and associated psychopathology. J Psychiatr Prac 20(4):316–323

    Article  Google Scholar 

  69. Davidson JR, Foa EB, Connor KM, Churchill LE (2002) Hyperhidrosis in social anxiety disorder. Prog Neuropsychopharmacol Biol Psychiatry 26:1327–1331

    Article  PubMed  Google Scholar 

  70. Ruchinskas RA, Narayan RK, Meagher RJ, Furukawa S (2002) The relationship of psychopathology and hyperhidrosis. Br J Dermatol 147(4):733–735

    Article  CAS  PubMed  Google Scholar 

  71. Hamm H (2014) Impact of hyperhidrosis on quality of life and its assessment. Dermatol Clin 32:467–476

    Article  CAS  PubMed  Google Scholar 

  72. Schneier FR, Heimberg RG, Liebowitz MR, Blanco C, Gorenstein LA (2012) Social anxiety and functional impairment in patients seeking surgical evaluation for hyperhidrosis. Compreh Psychiatr 53:1181–1186

    Article  Google Scholar 

  73. An JG, Liu YT, Xiao SX, Wang JM, Geng SM, Dong YY (2013) Quality of life of Patients with Neurodermatitis. Int J Med Sci 10(59):593–598

    Article  PubMed  PubMed Central  Google Scholar 

  74. Kretzmer GE, Gelkopf M, Kretzmer G, Melamed Y (2008) Idiopathic pruritus in psychiatric inpatients: an explorative study. Gen Hosp Psychaity 30:344–348

    Article  Google Scholar 

  75. Martin-Brufau R, Corbalan-Berna J, Ramirez-Andreo A, Brufau-Redondo C, Liminana-Gras R (2010) Personality differences between patients with lichen simplex chronicus and normal population. A study of pruritus. Eur J Dermatol 20(83):359–363

    PubMed  Google Scholar 

  76. Konuk N, Koca R, Atik L, Muhtar S, Atasoy N, Bostanci B (2007) Psychopathology, depression and dissociative experiences in patients with lichen simplex chronicus. Gen Hosp Psychiatry 29:232–235

    Article  PubMed  Google Scholar 

  77. Liao YH, Lin CC, Tsai PP, Shen WC, Sung FC, Kao CH (2014) Increased risk of lichen simplex chronicus in people with anxiety disorder. A nationwide population-based retrospective cohort study. Br J Dermatol 170:890–894

    Article  PubMed  Google Scholar 

  78. Brenaut E, Horreau C, Pouplard C, Barnetche T, Paul C, Richard MA, Joly P, Le Maitre A, Aractingi S, Aubin F, Cribier B, Jullien D, Ortonne JP, Misery L (2013) Alcohol consumtion and psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol 27(Suppl 3):30–35

    Article  PubMed  Google Scholar 

  79. Adamzik K, McAleer MA, Kirby B (2013) Alcohol and psoriasis: sobering thoughts. Clin Exp Dermatol 38:819–822

    Article  CAS  PubMed  Google Scholar 

  80. Zou L, Lonne-Rahm SB, Helander A, Stokkeland K, Franck J, Nordlind K (2015) Alcohol intake measured by phosphatidylethanol in blood and the lifetime drinking history interview are correlated with the extent of psoriasis. Dermatology 230:375–380

    Article  CAS  PubMed  Google Scholar 

  81. Dowlatshahi EA, Wakkee M, Arends L, Nijsten T (2014) The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and meta-analysis. J Investigat Dermatol 134:1542–1551

    Article  CAS  Google Scholar 

  82. Bangemann K, Schulz W, Wohlleben J, Weyergraf A, Snitjer I, Werfel T, Schmid-Ott G, Böhm D (2014) Depression und Angststörung bei Psoriasispatienten. Hautarzt 65:1056–1061

    Article  CAS  PubMed  Google Scholar 

  83. Martin-Brufau R, Romero-Brufau S, Martin-Gorgojo A, Brufau Redondo C, Corbalan J, Ulnik J (2015) Psoriasis lesions are associated with specific types of emotions. Emotional profile in psoriasis. Eur J Dermatol 25:329–334

    Google Scholar 

  84. Garshick MK, Kimball AB (2015) Psoriasis and the life cycle of persistent life effects. Dermatol Clin 33:25–39

    Article  CAS  PubMed  Google Scholar 

  85. Schmitt JM, Ford DE (2007) Role of depression in quality of life for patients with psoriasis. Dermatology 215(1):17–27

    Article  PubMed  Google Scholar 

  86. Noormohammadpour P, Fakour Y, Nazemei MJ, Ehsani A, Gholamali F, Morteza A, Mokhtari L, Khosrovanmehr N (2015) Evaluation of some psychological factors in psoriatic patients. Iran J Psychiatry 10:37–42

    PubMed  PubMed Central  Google Scholar 

  87. Schmitt J, Wozel G, Garzarolli M, Viehweg A, Bauer M, Leopold K (2014) Effectiveness of interdisciplinary vs. dermatological care of moderate-to-severe psoriasis: a pragmatic randomized controlled trial. Acta Derm Venereol 94:192–197

    Article  PubMed  Google Scholar 

  88. Gupta MA, Gupta AK, Chen SJ, Johnson AM (2005) Comorbidity of rosacea and depression: an analysis of the National Ambulatory Medical care Survey and National hospital Ambulatory Care Survey-Outpatient Departement data collected by the U.S. National Center for Health Statistics from 1995-to 2002. Br J Dermatol 153:1176–1181

    Article  CAS  PubMed  Google Scholar 

  89. Spoendlin J, Bichsel F, Voegel JJ, Jick SS, Meier CR (2014) The association between psychiatric diseases, psychotropic drugs and the risk of incident rosacea. Br J Dermatol 170:878–883

    Article  CAS  PubMed  Google Scholar 

  90. Scharschmidt TC, Yost JM, Truong SV, Steinhoff M, Wang KC, Berger TG (2011) Neorogenic Rosacea: a distinct clinical subtype requiring a modified approach to treatment. Arch Dermatol 147:123–126

    Article  PubMed  PubMed Central  Google Scholar 

  91. Steinhoff M, Buddenkotte J, Aubert J, Sulk M, Novak P, Schwab V, Mess C, Cevikbas F, Rivier M, Carlavan I, Deret S, Rosignoli C, Metze D, Luger TA, Voegel JJ (2011) Clinical, cellular and molecular aspects in the pathophysiology of Rosacea. J Investig Dermatol Symp Proc 15:2–11

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  92. Schwab V, Sulk M, Seeliger S, Novak P, Aubert J, Mess C, Rivier M, Carlavan I, Rossio P, Metze D, Buddenkotte J, Cevikbas F, Voegel JJ, Steinhoff M (2011) Neurovascular and neuroimmun aspects in the pathophysiology of Rosacea. J Investig Dermatol Symp Proc 15:53–62

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  93. Elewski BE (2009) Safe and effective treatment of seborrheic dermatitis. Cutis 83(6):333–338

    PubMed  Google Scholar 

  94. Maietta G, Fornaro P, Rongioletti F, Rebora A (1990) Patients with mood depression have a high prevalence of seborrhoeic dermatitis. Acta Derm Venereol 70:432–434

    CAS  PubMed  Google Scholar 

  95. Cömert A, Akbas B, Kilic EZ, Akin Ö, Gökce E, Göktuna Z, Taskapan O (2013) Psychaitric comorbidities and alexithymia in patients with seborrheic dermatitis: a questionnaire study in Turkey. Am J Clin Dermatol 14:335–342

    Article  PubMed  Google Scholar 

  96. Misery L, Touboul S, Vincot C, Dutray S, Rolland-Jacob G, Consoli SG, Farcet Y, Feton-Danou N, Cardinaud F, Callot V, De la Chapelle C, Pomey-Rey D, Consoli SM, Pour le Group Psychodermatologie (2007) Stress and seborrheic dermatitis. Ann Dermatol Venereol 134:833–837

    Article  CAS  PubMed  Google Scholar 

  97. Shapiro J, Wiseman M, Lui H (2000) Practical management of hair loss. Can Fam Physician 46:1469–1477

    CAS  PubMed  PubMed Central  Google Scholar 

  98. Whiting D (1996) Chronic telogen effluvium. Dermatol Clin 14(4):723–731

    Article  CAS  PubMed  Google Scholar 

  99. Harth W, Blume-Peytavi U (2013) Psychotrichology: psychosomatic aspects of hair diseases. JDDG. doi:10 1111/j.1610–0387.2012.o8034.x

    PubMed  Google Scholar 

  100. Wallengren J, Isaksson A (2007) Urticarial dermographism: clinical features and response to psychosocial stress. Acta Derm Venereol 87:493–498

    Article  PubMed  Google Scholar 

  101. Staubach P, Dechene M, Metz M, Magerl M, Siebenhaar F, Weller K, Zezula P, Eckhardt-Henn A, Maurer M (2011) High prevalence of mental disorders and emotional distress in patients with chronic spontaneous urticaria. Acta Derm Venereol 91:557–561

    Article  PubMed  Google Scholar 

  102. Calamita Z, Pela-Calamita AB (2013) Chronic spontaneous urticaria: epidemiological characteristics focusing on the histocompatibility profile and presence antibodies. Inflamm Allergy Drug Targets 12:8–11

    Article  CAS  PubMed  Google Scholar 

  103. Caffarelli C, Cuomo B, Cardinale F, Barberi S, Povesi Dascola C, Agostinis F, Franceschini F, Bernardini R (2013) Aetiological factors associated with chronic urticaria in children: a systematic review. Acta Derm Vener 93:268–272

    Article  Google Scholar 

  104. Liu TH, Lin YR, Yang KC, Tsai YG, Fu YC, Wu TK, Wu HP (2010) Significant factors associated with severity and outcome of an initial episode of acute urticaria in children. Pediatr Allergy Immunol 21:1043–1051

    Article  CAS  PubMed  Google Scholar 

  105. Kuo CL, Chen CY, Huang HL, Chen WL, Lee HC, Chang CY, Chou CC, Ho SY, Wu HP, Lin YR (2014) Increased risk of major depression subsequent to a first-attack and non-infection caused urticaria in adolescence. A nationwide population.based study. BMC Pediatr 14:181–189

    Article  PubMed  PubMed Central  Google Scholar 

  106. Ezzedine K, Eleftheriadou V, Whitton M, van Geel N (2015) Vitiligo. Lancet 386:74–84

    Article  PubMed  Google Scholar 

  107. De Barros JC, Machado Filho CD, Abreu LC, de Barros JA, Paschoal FM, Nomura MT, Marques E, Martins LC (2014) A study of clinical profiles of vitiligo in different ages: an analysis of 669 outpatients. Int J Dermatol 53:842–848

    Article  PubMed  Google Scholar 

  108. Ahmed I, Ahmed S, Nasreen S (2007) Frequency and pattern of psychiatric disorders in patients with vitiligo. J Ayub Med Coll Abbottabad 19:19–21

    PubMed  Google Scholar 

  109. Lindhorst Homan MW, Spuls PI, de Korte J, Bos JD, Sprangers MA, van der Veen JP (2009) The burden of vitiligo: patient characteristics associated with quality of life. J Am Acad Dermatol 61:411–420

    Article  Google Scholar 

  110. Wang KY, Wang KH, Zhang ZP (2011) Health-related quality of life and marital quality of vitiligo patients in China. J Eur Acad Dermatol Venereol 25:429–435

    Article  PubMed  Google Scholar 

  111. Karelson M, Silm H, Kingo K (2013) Quality of life and emotional state in vitiligo in an Estonia sample: comparison with psoriasis and healthy controls. Acta Derm Venereol 93:446–450

    Article  PubMed  Google Scholar 

  112. Papadopoulos L, Bor R, Legg C (1999) Coping with the disfiguring effects of vitiligo: A preliminary investigation into the effects of cognitive-behavioural therapy. Br J Med Psychol 72:385–396

    Article  PubMed  Google Scholar 

  113. Ruiz-Doblado S, Carrizosa A, Garcia-Hernandez MJ (2003) Alopecia areata: Psychiatric comorbidity and adjustment to illness. Int J Dermatol 42:434–437

    Article  PubMed  Google Scholar 

  114. Manolache L, Benea V (2007) Stress in patients with alopecia areata and vitiligo. J Eur Acad Dermatol Venereol 21:921–928

    Article  PubMed  Google Scholar 

  115. Grahovac T, Ruzic K, Sepic-Grahovac D, Dadic-Hero E, Radonja AP (2010) Depressive disorder and Alopecia. Psychiatr Danub 22(2):293–295

    PubMed  Google Scholar 

  116. Alfani S, Antinone V, Mozzetta A, DiPietro C, Mazzanti C, Stella P, Raskovich D, Abeni D (2012) Psychological status of patients with alopecia areata. Acta Derm Venereol 92:304–306

    Article  PubMed  Google Scholar 

  117. Abedini H, Farshi S, Mirabzadeh A, Keshavarz S (2014) Antidepressant effects of citalopram on treatment of alopecia areata in patients with major depressive disorder. J Dermatolog Treat 25:153–155

    Article  CAS  PubMed  Google Scholar 

  118. Jett K, Friedman JM (2010) Clinical and genetic aspects of neurofibromatosis 1. Genet Med 12(1):1–11

    Article  PubMed  Google Scholar 

  119. Belzeaux R, Lancon C (2006) Neurofibromatosis type 1: psychiatric disorders and quality of life impairment. Presse Med 35:277–280

    Article  PubMed  Google Scholar 

  120. Reichardt C, Scherwath A, Mautner VF, Bullinger M, Petersen-Ewert C (2013) Psychische Belastung von Erwachsenen mit Neurofibromatose Typ 1: Eine Längsschnittstudie. Psychother Psych Med 63:85–92

    Article  Google Scholar 

  121. Koo J, Gambla C (1996) Delusions of parasitosis and other forms of monosymptomatic hypochondrial psychosis. General discussion and case illustrations. Dermatol Clin 14:429–438

    Article  CAS  PubMed  Google Scholar 

  122. Gupta MA, Gupta AK (2013) Cutaneous sensory disorder. Semin Cutan Med Surg 32(2):110–118

    Article  PubMed  Google Scholar 

  123. Yosipovitch G, Ishiuji Y, Patel TS, Hicks MI, Oshiro Y, Kraft RA, Winnicki E, Coghill RC (2008) The brain processing of scratching. J Investig Dermatol 128:1806–1811

    Article  CAS  PubMed  Google Scholar 

  124. Bin Saif GA, Ericson ME, Yosipivitch G (2011) The itchy scalp-scratching for an explanation. Exp Dermatol 20:959–968

    Article  CAS  PubMed  Google Scholar 

  125. Papoiu ADP, Nattkemper LA, Sanders KM, Kraft RA, Yiong-Huak C, Coghill RC, Yosipovitch G (2013) Brain’s reward circuits mediate itch relief. A functional MRI study of active scratching. PLOS ONE 8:e82389

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  126. Tey HL, Wallengren J, Yosipovitch G (2013) Psychosomatic factors in pruritus. Clin Dermatol 31:31–40

    Article  PubMed  PubMed Central  Google Scholar 

  127. Ständer S, Raap U, Weisshaar E, Schmelz M, Mettang T, Handwerker H, Luger TA (2011) Pathogenesis of pruritus. J Dtsch Dermatol Ges 9:456–463

    PubMed  Google Scholar 

  128. Ishuij Y, Coghill RC, Patel TS et al (2009) Distinct patterns of brain activity evoked by histamine-induced itch reveal an association with itch intensity and disease severity in atopic dermatitis. Br J Dermatol 161:1072–1080

    Article  Google Scholar 

  129. Schneider G, Hockmann J, Stumpf A (2014) Psychosomatic aspects of prurigo nodularis. Hautarzt 65(8):704–708

    Article  CAS  PubMed  Google Scholar 

  130. Reiß M, Reiß G (2004) Das Burning Mouth Syndrom-Ursachen, Differentialdiagnose und Therapie. Ther Umsch 61:308–312

    Article  PubMed  Google Scholar 

  131. Coculescu EC, Tovaru S, Coculescu BI (2014) Epidemiological and etiological aspects of burning mouth syndrome. J Med Life 7(3):305–309

    CAS  PubMed  PubMed Central  Google Scholar 

  132. Trikkas C, Nikolatou O, Samara C, Bazopoulou-Kyrkanidou E, Rabavilas AD, Christodoulou GN (1996) Glossodynia: personality characteristics and psychopathology. Psychother Psychosom 65:163–168

    Article  CAS  PubMed  Google Scholar 

  133. Minguez-Sanz MP, Salort-Llorca C, Silvestre-Donat FJ (2011) Etiology of burning mouth syndrome: a review and update. Med Oral Patol Oral Cir Bucal 16:e1448

    Google Scholar 

  134. Wong JW, Koo JYM (2013b) Psychopharmacological therapies in dermatology. Dermatol Online J 19:1–7

    Google Scholar 

  135. Dadic-Hero E, Ruzic C, Grahovac T, Graovac M, Palijan TZ, Sepic-Grahovac D (2011) Allergic reactions outcome of sertraline and es-citalopram treatments. Psychiat Danubin 23:120–122

    Google Scholar 

  136. Gross CM, Klöcker M, Jacob T, Klecha D (2009) Dermatologische Nebenwirkungen unter Therapie mit Serotonin-Noradrenalin-Wiederaufnahmehemmern. Nervenarzt 79:1304–1309

    Article  Google Scholar 

  137. Diab M, Coloe J, Bechtel MA (2009) Bullous pemphigoid precipitated by galantamine hydrobromide. Cutis 83:139–140

    PubMed  Google Scholar 

  138. Ordonez L, Salgueiro E, Jimeno FJ, Manso G (2015) Spontaneous reporting of Steven-Johnson syndrome and toxic epidermal necrolysis associated with antiepileptic drugs. Eur Rev Med Pharmacol Sci 19:2732–2737

    CAS  PubMed  Google Scholar 

  139. Blaszczyk B, Lason W, Czuczwar SJ (2015) Antiepileptic drugs and adverse skin reactions: an update. Pharmacol Rep 67(3):426–434

    Article  CAS  PubMed  Google Scholar 

  140. Harth W, Seikowski K, Gieler U, Niemeier V, Hillert A (2007b) Psychopharmacological treatment of dermatological patients- when simply talking does not help. JDDG 12:1101–1107

    Article  Google Scholar 

  141. Shukla R, Sasseville D (2008) Psychopharmacology in Psychodermatology. J Cut Med Surg 12:255–267

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Psychiatrie Psychotherapie und Präventivmedizin, LWL-Universitätsklinikum der Ruhr Universität Bochum, Alexandrinenstr.1, 44791, Bochum, Deutschland

    P. Mavrogiorgou &  G. Juckel

Authors
  1. P. Mavrogiorgou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Juckel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G. Juckel.

Ethics declarations

Interessenkonflikt

P. Mavrogiorgou und G. Juckel geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mavrogiorgou, P., Juckel, G. Dermatologische Erkrankungen und ihre Bedeutung für die Psychiatrie. Nervenarzt 88, 254–267 (2017). https://doi.org/10.1007/s00115-016-0082-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00115-016-0082-4

Schlüsselwörter

Keywords

Search

Navigation